Dual VEGFR-2 and tubulin inhibitor
     
Home > PRODUCTS > Biochemicals > Dual VEGFR-2 and tubulin inhibitor

Newsletter Subscription

Stay updated with our new products and services. You can unsubscribe at any time.


Dual VEGFR-2 and tubulin inhibitor

(2,3-Dihydro-benzo[1,4]dioxin-6-yl)-(5-{2-[(pyridin-4-ylmethyl)-amino]-phenyl}-[1,3,4]oxadiazol-2-yl)-amine


Dual VEGFR-2 and tubulin inhibitor

OTAVAchemicals Catalogue Number:  7070707143

CAS Registry Number:  830333-53-4

Purity:  95%+

Ref.: Chekler et al. Discovery of Dual VEGFR-2 and Tubulin Inhibitors with in Vivo Efficacy. ACS Med. Chem. Lett. (2010), 1, 488-492

Abstract: In an effort to develop potent, orally bioavailable compounds for the treatment of neoplastic diseases, we developed a class of dual VEGFR-2 kinase and tubulin inhibitors. Targeting the VEGFR receptor kinase and tubulin structure allows for inhibition of both tumor cells and tumor vasculature. Previously, a combination of two compounds, a VEGF receptor tyrosine kinase inhibitor and tubulin agent, was demonstrated to produce an enhanced antitumor response in animal studies. We have reaffirmed their results, with the added benefit that both activities are found in one compound.

 
SSL